Schwartz Greg M, President Media & Marketplaces, sold 5,400 shares of the Zillow Group, Inc. (NASDAQ:Z) in an exchange that happened on January 2nd. The stock was sold at an average price of $31.44 per share, amounting to a transaction worth $169,800. The sale was made public in a document filed with the SEC. Additionally, President Media & Marketplaces Schwartz Greg M sold 5,400 shares of this stock in a transaction that took place on December 3rd. The stock was sold at an average price of $37.33 per share, for a total exchange amounting to $201,582. After the transaction, the President Media & Marketplaces Schwartz Greg M currently holds 0 shares of the company’s stock.
With this stock price’s latest movement, it is now -46.06% away from its 1-year high and 34.34% higher than its 1-year low price. In the past seven days, the stock price volatility for Zillow Group, Inc. was 3.74%, whereas its volatility in the past 30 days has been 4.27%.
Shares of Zillow Group, Inc. (Z) surged 3.44%, amounting to a gain of $1.18 per share, to finish the regular trading session at $35.44 on Saturday 02/09/2019. After beginning the session at $34, shares of Zillow Group, Inc. reached as high as $35.66 during the day, while hitting a 1-day low of $33.95. Trade volume reached 2,645,601 shares against this stock’s average daily volume of 3.04M shares, with a total float of 130.65M. As a consequence of the price increase, Zillow Group, Inc. now has a current market value of 4.93B.
Horizon Pharma Public Limited Company (NASDAQ:HZNP) added 0.48% to its trading price by the close of the most recent session, jumping from its previous closing price of $22.79 to $22.90. This stock increased in value by 4.04% during the last 7-day period, and experienced a gain of 8.07% over the past 30-day period. In the past three months, this stock’s price grew by 18.35% , and added 13.82% to its price during the last six months of trading. HZNP demonstrated a yearly price gain of 62.99% , while its year-to-date (YTD) price performance has been up 17.20% . This stock’s price changed by +27.65% compared to its 90-day low, and moved down -4.70% comparing to its 90-day high price.
Have a quick look on short, medium and long-term indicators. According to the Composite Indicator, Trendspotter rated the HZNP stock as “Buy”. In the short-term, Horizon Pharma Public Limited Company (HZNP) has a 20-day average volume of 1,391,090 shares and short-term indicators sets the HZNP stock as “ 80% Buy ” on average basis. In the medium-term, HZNP stock has a 50-Day average volume of 1,483,582 shares and medium-term indicators gave the average rating of “ 100% Buy ”, while in the long-term period the FB stock has a 100-Day average volume of 1,629,398 shares. On average, long-term indicators rated the stock as “100% Buy ”. The overall picture from all short, medium and long-term indicators sets the HZNP stock as “96% Buy ” on average basis.
Recently, multiple brokerages have sent out reports on HZNP. Mizuho, for example, Downgrade its rating on shares of Horizon Pharma Public Limited Company from “Buy ” to a “ Neutral”according to a research note from Thursday November 15th, 2018. while giving the stock a “ Neutral” from “Buy ” rating, as stated in a research report from Wednesday, June 27th, 2018. Mizuho, on the other hand, Upgrade a from “Neutral ” to “ Buy” rating on this stock, while posting a $18 price target on shares of this company’s stock in a research note dated Friday, January 12th, 2018.
In other news related to Horizon Pharma Public Limited Company stock, 93.42% shares of HZNP held by institutions. The total number of institutions who held the HZNP shares was 325, according to most recent SEC filling. During the past quarter, total 156,588,475 shares held by institutions with the net change of -1,038,319 shares. In the meantime, 24 new institutions bought the shares of Horizon Pharma Public Limited Company for the first time and 18 institutions sold all their holdings in the company’s common stock. 62 institutions increased their investment in the HZNP stock and 55 institutions decreased their investment in the Horizon Pharma Public Limited Company (HZNP)’s stock during the last quarter.